Gottlieb, Alice B., April W. Armstrong, Joseph F. Merola, Andrew Napoli, Miroslawa Nowak, Subhashis Banerjee, Thomas Lehman, and Philip J. Mease. 2024. “Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients With Active Psoriatic Arthritis: Results from a Phase 2 Trial”. SKIN The Journal of Cutaneous Medicine 8 (2):s383. https://doi.org/10.25251/skin.8.supp.383.